Christophe Fermé

3.3k total citations
30 papers, 1.6k citations indexed

About

Christophe Fermé is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christophe Fermé has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christophe Fermé's work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Christophe Fermé is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Christophe Fermé collaborates with scholars based in France, Belgium and Italy. Christophe Fermé's co-authors include Pauline Brice, L. Mignot, Jean Marc Extra, Fabien Calvo, M. Marty, Marc Espié, Bertrand Coiffier, Hervé Tilly, J Frija and Ali Guermazi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Christophe Fermé

29 papers receiving 1.5k citations

Peers

Christophe Fermé
Comparison fields: 5 of 89
  • Pathology and Forensic Medicine 795
  • Oncology 712
  • Pulmonary and Respiratory Medicine 419
  • Neurology 336
  • Molecular Biology 163
Replace Isabelle Moullet with:
Isabelle Moullet France
Fadhela Bouafia France
Juan‐Manuel Sancho Spain
Lois Ayash United States
G. Schellong Germany
Anna Russo Italy
Patrizio Mazza Italy
J. O. Armitage United States
R S Cox United States
Mathias Hänel Germany
Isabelle Moullet France View profile →
Citations per field, relative to Christophe Fermé
Christophe Fermé · 1×
Citations per year, relative to Christophe Fermé
Christophe Fermé · 1×

Countries citing papers authored by Christophe Fermé

Since Specialization
Citations

This map shows the geographic impact of Christophe Fermé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Fermé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Fermé more than expected).

Fields of papers citing papers by Christophe Fermé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Fermé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Fermé. The network helps show where Christophe Fermé may publish in the future.

Co-authorship network of co-authors of Christophe Fermé

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Fermé. A scholar is included among the top collaborators of Christophe Fermé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Fermé. Christophe Fermé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 6
3 75
4 45
5 12
6 35
7 57
8 13
9 54
10 53
11 14
12 215
13
Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).
4
14 17
15 190
16 103
17 47
18
Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer.
6
19 6
20 295

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026